株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

MediPoint:生体吸収性ステント - 現在の主要企業と将来有望な企業

MediPoint: Bioabsorbable Stents - Current and Future Players

発行 GlobalData 商品コード 260984
出版日 ページ情報 英文 72 Pages
即納可能
価格
本日の銀行送金レート: 1USD=115.18円で換算しております。

2016年12月31日まで 年末キャンペーン割引: GlobalData社発行レポート
ご注意: ショッピングカートでは適用されませんので、割引価格についてはお問い合わせください

Back to Top
MediPoint:生体吸収性ステント - 現在の主要企業と将来有望な企業 MediPoint: Bioabsorbable Stents - Current and Future Players
出版日: 2012年12月31日 ページ情報: 英文 72 Pages
概要

当レポートでは、持続的な成長を続ける生体吸収性ステント(BAS)市場に関する詳細な分析を行っており、同市場を形成/牽引する主要企業や新規参入企業の分析、開発中のパイプライン製品などの情報を、概略以下の構成でお届けします。

第1章 目次

第2章 イントロダクション

  • 調査の動機
  • 関連レポート

第3章 競合評価

  • 概要
  • Absorb BVS - Abbott Vascular
  • Remedy - 京都医療設計

第4章 パイプライン製品

  • 概要
  • 開発段階別のパイプライン - 冠動脈疾患(CAD)
  • パイプライン製品のプロファイル - 冠動脈疾患(CAD)
  • 開発段階別のパイプライン - 末梢動脈疾患(PAD)
  • パイプライン製品のプロファイル- 末梢動脈疾患(PAD)

第5章 現在のプレーヤーと将来有望なプレーヤー

  • 概要
  • 企業戦略における動向
  • 企業プロファイル

第6章 付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDME1002FPR

Summary

GlobalData has released its medical device report, MediPoint: Bioabsorbable Stents - Current and Future Players. The report is a vital source of up-to-date information with in-depth analysis on the companies in the steadily growing Bioabsorbable Stent (BAS) Market. The report identifies and analyzes the key companies shaping and driving the global Bioabsorbable Stent market. The report provides insight into the competitive BAS landscape, including new companies entering the market and pipeline products in development. This report is built using data and information sourced from proprietary databases, primary and secondary and in-house analysis by GlobalData's team of industry experts.

Scope

  • Investigation of current and future market competition for Bioabsorbable Stents.
  • Competitor assessment including device approval analysis.
  • Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.
  • Strategic assessment of the device sector through market impact analysis, future market scenario and company analysis.
  • Direct quotes from Key Opinion Leaders (KOL) as well as interventional cardiologists and radiologists already using these novel devices.

Reasons to buy

  • Gain a high level view of the trends shaping and driving the Bioabsorbable Stent Market.
  • Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
  • Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape
  • Take a comprehensive look at the market's device pipeline and identify promising, paradigm-shifting products.
  • Create an effective counter-strategy to gain a competitive advantage against those currently in the market

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Catalyst
  • 2.2. Related Reports

3. Competitive Assessment

  • 3.1. Overview
  • 3.2. Absorb BVS - Abbott Vascular
    • 3.2.1. Efficacy
    • 3.2.2 SWOT Analysis
  • 3.3. Remedy - Kyoto Medical Planning
    • 3.3.1. Efficacy
    • 3.3.2 SWOT Analysis

4. Pipeline Products

  • 4.1. Overview
  • 4.2. Pipeline by Phases in Development - Coronary Artery Disease
  • 4.3. Pipeline Product Profiles - Coronary Artery Disease
    • 4.3.1. Igaki-Tamai Stent
    • 4.3.2. ReZolve Sirolimus Eluting Bioabsorbable Coronary Scaffold
    • 4.3.3. Drug-Eluting Absorbable Metal Scaffold
    • 4.3.4. Absorbable Metal Stents
    • 4.3.5. DESolve Bioabsorbable Coronary Scaffold System
    • 4.3.6. ART Stent
    • 4.3.7. The OrbusNeich Stent
    • 4.3.8. TephaFLEX Absorbable Stent
    • 4.3.9. The Arterius Stent
    • 4.3.10. Zorion Medical Stent
    • 4.3.11. 3V Avatar
    • 4.3.12. Biosorb
    • 4.3.13. Summary
  • 4.4. Pipeline by Phases in Development - Peripheral Artery Disease
  • 4.5. Pipeline Product Profiles- Peripheral Artery Disease
    • 4.5.1. Magic Explorer Stent
    • 4.5.2. Esprit Bioabsorbable Vascular Scaffold
    • 4.5.3. ART Stent
    • 4.5.4. TephaFLEX Absorbable Peripheral Stent
    • 4.5.5. Zorion Medical Stent
    • 4.5.6. Amaranth Medical Stent
    • 4.5.7. Summary

5. Current and Future Players

  • 5.1. Overview
  • 5.2. Trends in Corporate Strategy
  • 5.3. Company Profiles
    • 5.3.1. Abbott Vascular
    • 5.3.2. Kyoto Medical Planning Co., Ltd
    • 5.3.3. Biotronik SE & Co. KG
    • 5.3.4. REVA Medical, Inc.
    • 5.3.5. Elixir Medical Corporation
    • 5.3.6. Arterial Remodeling Technologies
    • 5.3.7. Tepha, Inc.
    • 5.3.8. OrbusNeich
    • 5.3.9. Arterius
    • 5.3.10. Zorion Medical
    • 5.3.11. S3V Vascular Technologies
    • 5.3.12. ICON Interventional Systems
    • 5.3.13. Amaranth Medical
    • 5.3.14. Medlogics Device Corporation

6. Appendix

  • 6.1. Bibliography
  • 6.2. Abbreviations
  • 6.3. Report Methodology
    • 6.3.1. Overview
    • 6.3.2. Coverage
    • 6.3.3. Secondary Research
    • 6.3.4. Forecasting Methodology
  • 6.4. Physicians and Specialists Included in this Study
  • 6.5. Physician Survey
  • 6.6. About the Authors
    • 6.6.1. Analysts
    • 6.6.2. Global Head of Healthcare
  • 6.7. About MediPoint
  • 6.8. About GlobalData
  • 6.9. Contact Us
  • 6.10. Disclaimer

List of Tables

  • Table 1: Marketed Bioabsorbable Stent Products
  • Table 2: Absorb BVS Product Portfolio
  • Table 3: Absorb BVS SWOT Analysis, 2012
  • Table 4: Remedy Stent Product Portfolio
  • Table 5: Remedy SWOT Analysis, 2012
  • Table 6: BAS Global Product Pipeline (Coronary)
  • Table 7: Igaki-Tamai Stent SWOT Analysis, 2012
  • Table 8: ReZolve Stent SWOT Analysis, 2012
  • Table 9: DREAMS SWOT Analysis, 2012
  • Table 10: AMS SWOT Analysis, 2012
  • Table 11: BAS Global Product Pipeline (Peripheral)
  • Table 12: Magic Explorer Stent SWOT Analysis, 2012
  • Table 13: Esprit BVS SWOT Analysis, 2012
  • Table 14: Company Profile - Abbott Vascular
  • Table 15: Marketed Bioabsorbable Stent Products by Abbott Vascular
  • Table 16: Pipeline Bioabsorbable Stent Products by Abbott Vascular
  • Table 17: Abbott Vascular SWOT Analysis, 2012
  • Table 18: Company Profile - Kyoto Medical Planning
  • Table 19: Marketed Bioabsorbable Stent Products by Kyoto Medical Planning
  • Table 20: Pipeline Bioabsorbable Stent Products by Kyoto Medical Planning
  • Table 21: Kyoto Medical Planning SWOT Analysis, 2012
  • Table 22: Company Profile - Biotronik
  • Table 23: Pipeline Bioabsorbable Stent Products by Biotronik
  • Table 24: Biotronik SWOT Analysis, 2012
  • Table 25: Company Profile - REVA Medical
  • Table 26: Pipeline Bioabsorbable Stent Products by REVA Medical
  • Table 27: REVA Medical SWOT Analysis, 2012
  • Table 28: Company Profile - Elixir Medical Corporation
  • Table 29: Pipeline Bioabsorbable Stent Products by Elixir Medical Corporation
  • Table 30: Elixir Medical Corporation SWOT Analysis, 2012
  • Table 31: Company Profile - Arterial Remodeling Technologies
  • Table 32: Pipeline Bioabsorbable Stent Products by Arterial Remodeling Technologies
  • Table 33: Arterial Remodeling Technologies SWOT Analysis, 2012
  • Table 34: Company Profile - Tepha
  • Table 35: Pipeline Stent Products by Tepha
  • Table 36: Tepha SWOT Analysis, 2012
  • Table 37: Company Profile - OrbusNeich
  • Table 38: Pipeline Bioabsorbable Stent Products by OrbusNeich
  • Table 39: OrbusNeich SWOT Analysis, 2012
  • Table 40: Company Profile - Arterius
  • Table 41: Arterius SWOT Analysis, 2012
  • Table 42: Company Profile - Zorion Medical
  • Table 43: Zorion Medical SWOT Analysis, 2012
  • Table 44: Company Profile - S3V Vascular Technologies
  • Table 45: S3V Vascular Technologies SWOT Analysis, 2012
  • Table 46: Company Profile - ICON Interventional Systems
  • Table 47: ICON Interventional Systems SWOT Analysis, 2012
  • Table 48: Company Profile - Amaranth Medical
  • Table 49: Amaranth Medical SWOT Analysis, 2012
  • Table 50: Company Profile - Medlogics Device Corporation
  • Table 51: Medlogics Device Corporation SWOT Analysis, 2012
  • Table 52: Physicians Surveyed, By Country

List of Figures

  • Figure 1: BAS Coronary Pipeline by Stage in Clinical Development, 2012
  • Figure 2: BAS Peripheral Pipeline by Stage in Clinical Development, 2012
  • Figure 3: Kyoto Medical Planning Co., Ltd. Sales Volume ($m), May 2002-May 2012
Back to Top